Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2017/07/009057
CTRI/2017/07/009057
Recruiting
Phase 4

â??Clinical evaluation of Nalbuphine as an adjuvant to local anaesthetic in Supra Clavicular Brachial Plexus Block for Upper Limb Orthopedic Surgeris: A Prospective, Randomized, Double Blind Study.â??

Department of Anaesthesiology And Sir Takhatsinhji Hospital0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- patients posted for upper limb orthopaedic surgery of 18 to 60 yrs of age belonging to ASA I and II

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- patients posted for upper limb orthopaedic surgery of 18 to 60 yrs of age belonging to ASA I and II
Sponsor
Department of Anaesthesiology And Sir Takhatsinhji Hospital
Enrollment
100
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Anaesthesiology And Sir Takhatsinhji Hospital

Eligibility Criteria

Inclusion Criteria

  • •Informed written consent for participation in study.
  • •Gender: Either gender.
  • •Patients scheduled for elective upper limb orthopedic surgery
  • •ASA physical status I and II.
  • •BMI \<\= 25kg/m2\.

Exclusion Criteria

  • •1\.Patients refusing consent.
  • •2\.Contraindications to regional anesthesia:
  • •Previous nerve injury.
  • •History of drug dependence/abuse.
  • •History of drug allergy.
  • •Allergic to local anaesthetics.
  • •Patients taking analgesics and sedatives.
  • •Patients on anticoagulants.
  • •History of bleeding disorders.
  • •Psychiatric illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
se of nalbuphine drug as an additive with 0.5 percent levobupivacaine for upper limb orthopedic surgery in ultrasound guided supraclavicular block.Health Condition 1: O- Medical and Surgical
CTRI/2023/07/055741School of Medical Science And Research And Sharda Hospital, Greater Noida
Completed
Phase 4
Efficacy of nalbuphine as an adjuvant to levobupivacaine scalp nerve block on intraoperative hemodynamic response and postoperative analgesia in elective supratentorial craniotomyScalp nerve block, Supratentorial craniotomy, Hemodynamic response, Postoperative analgesia, Levobupivacaine, Nalbuphine
TCTR20221124002Department of anesthesiology, King chulalongkorn Memorial hospital60
Not yet recruiting
Phase 3
To study the effect of Nalbuphine in prolongation of duration of post-operative analgesia when it is added as an adjuvant to 0.5%Ropivacaine in ultrasound guided supraclavicular brachial plexus blocksHealth Condition 1: S52- Fracture of forearm
CTRI/2022/06/043470Department of Anaesthesia
Not yet recruiting
Not Applicable
Effect of Intrathecal Nalbuphine added to hyperbaric Ropivacaine on post operative pain in abdominal uterus removal surgeries under spinal anaesthesia
CTRI/2022/08/044953SMSRSharda University sharda hospital greter noida
Not yet recruiting
Not Applicable
Comparison of nalbuphine with both levobupivacaine heavy 0.5% versus ropivacaine heavy 0.75% intrathecally for surgeries under spinal anaesthesia
CTRI/2023/02/049589Mahatma Gandhi medical college and hospital